Liquid Handling System Market Trends

Increasing investments in drug and vaccine development to boost the market growth

The main reasons propelling the growth of the liquid handling system market are the increase in investments in drug discovery, the increase in R&D spending, the rise in the need for high-output screening, and the rise in the use of automation in clinical settings. Rising R&D initiatives for novel drug development and biotechnology research also fuel the market's expansion.

The development of vaccines and increasing investment by new drug companies are boosting the market for liquid handling systems. Manufacturers are releasing new drugs to fight disease incidence and spur market expansion. Adopting liquid handling systems that can handle high numbers of PCR tests with precise clinical results accelerates R&D and testing volume, driving market CAGR.

The Global Liquid Handling System Market Industry experiences a notable surge in demand for automation across laboratories and manufacturing sectors. Automation enhances precision and efficiency, reducing human error in liquid handling processes. As industries increasingly adopt automated solutions, the market is projected to reach 5.64 USD Billion in 2024. This trend is particularly evident in pharmaceutical and biotechnology sectors, where the need for high-throughput screening and reproducibility drives the adoption of advanced liquid handling systems. The integration of robotics and software solutions further propels this growth, indicating a shift towards more sophisticated laboratory environments.

Leading market players invest a lot of money in R&D to expand their product portfolios, which will spur further market growth for liquid handling system . With significant industry changes like new product releases, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations, market participants are also undertaking various strategic activities to expand their global presence. To grow and thrive in a market where competition and prices are growing, competitors in the liquid handling system sector must offer affordable products.

Manufacturing locally to cut operating costs is one of the main business tactics manufacturers use in the Liquid Handling System industry to benefit customers and develop the market sector. The liquid handling system market major player such as Agilent Technologies, Danaher Corporation,  Thermo Fisher Scientific Inc, Eppendorf AG, Tecan Group Ltd, and others are working on expanding the market demand by investing in research and development activities.

The global headquarters of the American corporation Agilent Technologies, Inc. is in Santa Clara, California. Agilent offers a broad range of technological platforms to analytical laboratories and clinical and routine diagnostics sectors. They comprise vacuum technologies, automation, bioreagents, FISH probes, gas and liquid chromatography, immunohistochemistry, informatics, mass spectrometry, microarrays, spectroscopy, target enrichment, and informatics.

In December 2022, Agilent Technologies and Fluid Management Systems (FMS), a pioneer in automated sample preparation systems, will collaborate to develop and market workflows for the testing and analysis of persistent organic pollutants (POPs), such as PFAS, Dioxins, PCBs, and other emerging contaminants in environmental and food matrices.

With its corporate headquarters in Washington, DC, the Danaher Corporation is an American multinational conglomerate. The business develops, produces, and sells industrial, commercial, professional, and medical goods and services. "Life Sciences," "Diagnostics," and "Environmental & Applied Solutions" are the three platforms used by the company. The corporation is named after the western Montana location of Danaher Creek. Mitchell Rales and Steven M. Rales, the company's founders, first had the idea while fishing there. Danaher Corporation announced in November 2022 that it had partnered strategically with Duke University to establish the first Danaher Beacon for Gene Therapy Innovation.